Source disclosure: February 06, 2026
KAINOS Laboratories,Inc. [4556.T]
TOKYO — Kainos Laboratories, Inc., represented by President and CEO Etsu Hirohiro (stock code 4556 on the Tokyo Stock Exchange Standard), announced today that its board of directors has revised the company's fiscal year 2026 March-end dividend forecast to zero, contingent upon the successful tender offer made by Flowers Corporation. The decision was disclosed following a board meeting held on February 6, 2026.
The revised dividend forecast reflects a significant change from the previous estimate of ¥32 per share. According to the press release issued alongside this announcement, the board supports the tender offer initiated by Flowers Corporation, recommending shareholders to tender their shares. This recommendation is based on the premise that Flowers Corporation aims to fully acquire Kainos Laboratories through the tender process, leading to the delisting of the company’s stock.
In a statement provided by the company, it was noted that while shareholder returns have been an important focus of management, the revised forecast takes into account the comprehensive evaluation conducted by Flowers Corporation regarding the tender price. This valuation assumes no end-of-period dividends will be paid as of March 31, 2026. As such, the board decided to revise the dividend forecast accordingly.
For reference, the company reported a dividend payout of ¥35 per share in the fiscal year ending March 2025. The full details of the board resolution can also be found in the separate press release issued by Kainos Laboratories, Inc., which outlines the rationale behind supporting the tender offer and the subsequent steps planned.
AI-translated content. 🟢 Confidence: High See terms • Original filing